Experiment: 2KTV

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D DQF-COSY	1 MM C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
2	2D 1H-15N HSQC	0.8 MM [U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
3	3D HNCA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
4	3D HNCACB	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
5	3D HN(CO)CA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
6	3D CBCA(CO)NH	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
7	3D HBHA(CO)NH	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
8	3D HNCO	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
9	3D HNHA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
10	3D 1H-15N NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
11	3D 1H-13C NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
12	3D HCCH-TOCSY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
13	3D HNCA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
14	3D HNCACB	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
15	3D HN(CO)CA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
16	3D CBCA(CO)NH	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
17	3D HBHA(CO)NH	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
18	3D HNCO	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
19	3D HNHA	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
20	3D 1H-15N NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
21	3D 1H-13C NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
22	3D HCCH-TOCSY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
23	2D 1H-13C HSQC	1 MM C_ERF1_ HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 5 % DMPC/DHPC/ SDS	90% H2O/10% D2O	0.08	7.0	AMBIENT	298
24	3D 1H-15N NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	311
25	3D 1H-13C NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE	90% H2O/10% D2O	0.08	7.0	AMBIENT	311
26	3D 1H-15N NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	311
27	3D 1H-13C NOESY	0.8 MM [U-99% 13C U-99% 15N] C_ERF1_HUMAN, 50 MM POTASSIUM CHLORIDE, 10 MM POTASSIUM PHOSPHATE, 100% D2O	90% H2O/10% D2O	0.08	7.0	AMBIENT	311

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	700
3	Varian	INOVA	600
4	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	24
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS	2.1	BRUNGER, ADAMS, CLORE, DELANO, GROS, GROSSE- KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN
2	collection	VNMR		Varian
3	collection	TopSpin		Bruker Biospin
4	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	structure solution	Sparky		Goddard
6	data analysis	TALOS		Cornilescu, Delaglio and Bax
7	data analysis	Anglesearch	2.10	Polshakov VI & Feeney J.
8	structure solution	CNS	2.1	BRUNGER, ADAMS, CLORE, DELANO, GROS, GROSSE- KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN
9	structure solution	ARIA		Linge, O'Donoghue and Nilges
10	structure solution	CNSSOLVE		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

2KTV

Human eRF1 C-domain, "open" conformer